249 related articles for article (PubMed ID: 34409042)
1. Identification of Claudin-6 as a Molecular Biomarker in Pan-Cancer Through Multiple Omics Integrative Analysis.
Zhang C; Guo C; Li Y; Liu K; Zhao Q; Ouyang L
Front Cell Dev Biol; 2021; 9():726656. PubMed ID: 34409042
[TBL] [Abstract][Full Text] [Related]
2. An integrative analysis of enhancer of yellow 2 homolog (ENY2) as a molecular biomarker in pan-cancer.
Chen Q; Shi X; Bao Y; Sun G; Wu S; Chen Y
Funct Integr Genomics; 2023 Mar; 23(1):72. PubMed ID: 36862319
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer.
Kojima M; Sugimoto K; Tanaka M; Endo Y; Kato H; Honda T; Furukawa S; Nishiyama H; Watanabe T; Soeda S; Fujimori K; Chiba H
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32987797
[TBL] [Abstract][Full Text] [Related]
4. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
Guo B; Wang Y; Liu W; Zhang S
Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
[TBL] [Abstract][Full Text] [Related]
5. The tight junction protein claudin 6 is a potential target for patient-individualized treatment in esophageal and gastric adenocarcinoma and is associated with poor prognosis.
Simon AG; Lyu SI; Laible M; Wöll S; Türeci Ö; Şahin U; Alakus H; Fahrig L; Zander T; Buettner R; Bruns CJ; Schroeder W; Gebauer F; Quaas A
J Transl Med; 2023 Aug; 21(1):552. PubMed ID: 37592303
[TBL] [Abstract][Full Text] [Related]
6. Integrative analysis identifies AKAP8L as an immunological and prognostic biomarker of pan-cancer.
Zhou L; Mei J; Cao R; Liu X; Fu B; Ma M; Gong B; Luo L; Liu Y; Zhu Q; Meng X
Aging (Albany NY); 2023 Sep; 15(17):8851-8872. PubMed ID: 37683130
[TBL] [Abstract][Full Text] [Related]
7. Association of CLDN6 and CLDN10 With Immune Microenvironment in Ovarian Cancer: A Study of the Claudin Family.
Gao P; Peng T; Cao C; Lin S; Wu P; Huang X; Wei J; Xi L; Yang Q; Wu P
Front Genet; 2021; 12():595436. PubMed ID: 34249076
[TBL] [Abstract][Full Text] [Related]
8. A paradigm shift in cancer research based on integrative multi-omics approaches: glutaminase serves as a pioneering cuproptosis-related gene in pan-cancer.
Shi HH; Mugaanyi J; Lu C; Li Y; Huang J; Dai L
BMC Womens Health; 2024 Apr; 24(1):213. PubMed ID: 38566121
[TBL] [Abstract][Full Text] [Related]
9. Chromosomally Unstable Gastric Cancers Overexpressing Claudin-6 Disclose Cross-Talk between HNF1A and HNF4A, and Upregulated Cholesterol Metabolism.
Dwivedi S; Hernández-Montes G; Montaño LF; Rendón-Huerta EP
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430456
[TBL] [Abstract][Full Text] [Related]
10. Claudin-6 is a single prognostic marker and functions as a tumor-promoting gene in a subgroup of intestinal type gastric cancer.
Kohmoto T; Masuda K; Shoda K; Takahashi R; Ujiro S; Tange S; Ichikawa D; Otsuji E; Imoto I
Gastric Cancer; 2020 May; 23(3):403-417. PubMed ID: 31654186
[TBL] [Abstract][Full Text] [Related]
11. Evidence Based on an Integrative Analysis of Multi-Omics Data on METTL7A as a Molecular Marker in Pan-Cancer.
Liu Z; Chen Y; Shen T
Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830565
[TBL] [Abstract][Full Text] [Related]
12. miR-149-3p Is a Potential Prognosis Biomarker and Correlated with Immune Infiltrates in Uterine Corpus Endometrial Carcinoma.
Lu X; Jing L; Liu S; Wang H; Chen B
Int J Endocrinol; 2022; 2022():5006123. PubMed ID: 35719192
[TBL] [Abstract][Full Text] [Related]
13. SPC25 Functions as a Prognostic-Related Biomarker, and Its High Expression Correlates with Tumor Immune Infiltration and UCEC Progression.
Liao LX; Zhang M; Xu X; Zhang S; Guo YZ
Front Biosci (Landmark Ed); 2024 Feb; 29(2):69. PubMed ID: 38420826
[TBL] [Abstract][Full Text] [Related]
14. Identification of the prognostic value of a 2-gene signature of the WNT gene family in UCEC using bioinformatics and real-world data.
Hu Y; Zheng M; Zhang D; Gou R; Liu O; Wang S; Lin B
Cancer Cell Int; 2021 Sep; 21(1):516. PubMed ID: 34565373
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Analysis of the Expression and Prognosis for MCM4 in Uterine Corpus Endometrial Carcinoma.
Pei LP; Zhang YZ; Li GY; Sun JL
Front Genet; 2022; 13():890591. PubMed ID: 35719366
[No Abstract] [Full Text] [Related]
16. RPP40 is a prognostic biomarker and correlated with tumor microenvironment in uterine corpus endometrial carcinoma.
Tang J; Tian X; Min J; Hu M; Hong L
Front Oncol; 2022; 12():957472. PubMed ID: 36091104
[TBL] [Abstract][Full Text] [Related]
17. The Src-Family Kinases SRC and BLK Contribute to the CLDN6-Adhesion Signaling.
Ichikawa-Tomikawa N; Sugimoto K; Kashiwagi K; Chiba H
Cells; 2023 Jun; 12(13):. PubMed ID: 37443730
[TBL] [Abstract][Full Text] [Related]
18. Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer.
Micke P; Mattsson JS; Edlund K; Lohr M; Jirström K; Berglund A; Botling J; Rahnenfuehrer J; Marincevic M; Pontén F; Ekman S; Hengstler J; Wöll S; Sahin U; Türeci O
Int J Cancer; 2014 Nov; 135(9):2206-14. PubMed ID: 24710653
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of claudin-6 contributes to malignant potentials and drug resistance of cervical adenocarcinoma.
Ito Y; Takasawa A; Takasawa K; Murakami T; Akimoto T; Kyuno D; Kawata Y; Shano K; Kirisawa K; Ota M; Aoyama T; Murata M; Sugimoto K; Chiba H; Saito T; Osanai M
Cancer Sci; 2022 Apr; 113(4):1519-1530. PubMed ID: 35100472
[TBL] [Abstract][Full Text] [Related]
20. Effects of the Tight Junction Protein CLDN6 on Cell Migration and Invasion in High-Grade Meningioma.
Yang A; Yang X; Wang J; Wang X; Wu H; Fan L; Li H; Li J
World Neurosurg; 2021 Jul; 151():e208-e216. PubMed ID: 33862296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
